Sana CEO reveals details about stealthy gene therapy startup that has raised more than $700M

Luke Timmerman interviews Sana Biotechnology CEO Steve Harr at the GeekWire Summit this week.

Sana Biotechnology CEO Steve Harr shed more light on one of most secretive, heavily funded startups in Seattle and the global biotech industry — detailing its plans to create tools that replace and

This post was originally published on this site

contactedorg

Check out http://contacted.org